Atria Investments’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,487
Closed -$212K – 2112
2026
Q1
$212K Sell
10,487
-264
-2% -$5.87K ﹤0.01% 1954
2025
Q4
$206K Buy
10,751
+419
+4% +$8.82K ﹤0.01% 1960
2025
Q3
$249K Buy
+10,332
New +$241K ﹤0.01% 1828

Other funds holding ADNT

Atria Investments's ADNT Position: Q2 2026 in Review

Atria Investments sold out of Adient (ADNT) in Q2 2026, closing a stake of 10,487 shares — an estimated $212K sold.

Atria Investments first reported a position in ADNT in Q3 2025 and held it in 3 quarters. The position peaked at $249K in Q3 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Atria Investments reported no remaining Adient position as of Q2 2026 after selling out during the quarter.
  • Atria Investments sold 10,487 Adient shares in Q2 2026, an estimated $212K.
  • Atria Investments first reported a position in Adient in Q3 2025 and held it in 3 quarters.
  • Atria Investments's Adient position peaked at $249K in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.